ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹97 Cr | ₹106 Cr | ₹78 Cr | ₹60 Cr | ₹68 Cr |
What is the latest Total Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹97 Cr |
| Mar2024 | ₹106 Cr |
| Mar2023 | ₹78 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹68 Cr |
How is Total Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹97 Cr | -9.03 | |
| Mar2024 | ₹106 Cr | 37.12 | |
| Mar2023 | ₹78 Cr | 28.37 | |
| Mar2022 | ₹60 Cr | -10.56 | |
| Mar2021 | ₹68 Cr | - | |
Compare Total Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,347.5 Cr | -3% | 9.3% | 2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | 0.3% | -3.7% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 2.4% | 6.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -0.8% | -1.5% | 25.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 7.9% | 4.6% | 4.6% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.5% | 5.4% | -18.5% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -3% |
9.3% |
2.6% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses